Molecular Biology of the Cell track citations

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E05-08-0709 on June 28, 2006

Vol. 17, Issue 9, 3870-3880, September 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
E05-08-0709v1
17/9/3870    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schilling, K.
Right arrow Articles by Icking, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schilling, K.
Right arrow Articles by Icking, A.

Translocation of Endothelial Nitric-Oxide Synthase Involves a Ternary Complex with Caveolin-1 and NOSTRINFormula

Kirstin Schilling*, Nils Opitz*, Anja Wiesenthal, Stefanie Oess, Ritva Tikkanen, Werner Müller-Esterl, and Ann Icking

Institute of Biochemistry II, University of Frankfurt Medical School, D-60590 Frankfurt, Germany

Submitted August 2, 2005; Revised June 14, 2006; Accepted June 15, 2006
Monitoring Editor: Robert Parton

Recently, we characterized a novel endothelial nitric-oxide synthase (eNOS)-interacting protein, NOSTRIN (for eNOS-trafficking inducer), which decreases eNOS activity upon overexpression and induces translocation of eNOS away from the plasma membrane. Here, we show that NOSTRIN directly binds to caveolin-1, a well-established inhibitor of eNOS. Because this interaction occurs between the N terminus of caveolin (positions 1–61) and the central domain of NOSTRIN (positions 323–434), it allows for independent binding of each of the two proteins to eNOS. Consistently, we were able to demonstrate the existence of a ternary complex of NOSTRIN, eNOS, and caveolin-1 in Chinese hamster ovary (CHO)-eNOS cells. In human umbilical vein endothelial cells (HUVECs), the ternary complex assembles at the plasma membrane upon confluence or thrombin stimulation. In CHO-eNOS cells, NOSTRIN-mediated translocation of eNOS involves caveolin in a process most likely representing caveolar trafficking. Accordingly, trafficking of NOSTRIN/eNOS/caveolin is affected by altering the state of actin filaments or cholesterol levels in the plasma membrane. During caveolar trafficking, NOSTRIN functions as an adaptor to recruit mediators such as dynamin-2 essential for membrane fission. We propose that a ternary complex between NOSTRIN, caveolin-1, and eNOS mediates translocation of eNOS, with important implications for the activity and availability of eNOS in the cell.


Formula The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).

This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05-08-0709) on June 28, 2006.

* These authors contributed equally to this work.

Address correspondence to: Werner Müller-Esterl (wme{at}biochem2.de)

Abbreviations used: eNOS, endothelial nitric-oxide synthase; HUVEC, human umbilical vein endothelial cell; Lat A, latrunculin A; MbetaCD, methyl-beta-cyclodextrin; NOSTRIN, endothelial nitric-oxide synthase-trafficking inducer; PM, plasma membrane; TfR, transferring receptor; TGN, trans-Golgi network.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. M. Dudzinski and T. Michel
Life history of eNOS: Partners and pathways
Cardiovasc Res, July 15, 2007; 75(2): 247 - 260.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2006 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.